Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
Persano I, Parlagreco E, La Salvia A, Audisio M, Volante M, Buttigliero C, Scagliotti GV, Brizzi MP. Persano I, et al. Among authors: parlagreco e. Semin Oncol. 2022 Dec;49(6):476-481. doi: 10.1053/j.seminoncol.2023.01.007. Epub 2023 Feb 2. Semin Oncol. 2022. PMID: 36759234 Review.
Ocular metastases from neuroendocrine tumors: A literature review.
La Salvia A, Persano I, Trevisi E, Parlagreco E, Muratori L, Scagliotti GV, Brizzi MP. La Salvia A, et al. Among authors: parlagreco e. Semin Oncol. 2020 Apr-Jun;47(2-3):144-147. doi: 10.1053/j.seminoncol.2020.04.003. Epub 2020 May 6. Semin Oncol. 2020. PMID: 32402472 Review.
Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review.
La Salvia A, Portigliatti Pomeri A, Persano I, Trevisi E, Parlagreco E, Colombi N, Brizzi MP, Picci RL, Oliva F. La Salvia A, et al. Among authors: parlagreco e. Compr Psychiatry. 2021 Aug;109:152244. doi: 10.1016/j.comppsych.2021.152244. Epub 2021 May 19. Compr Psychiatry. 2021. PMID: 34120056 Free article. Review.
Repositioning PARP inhibitors in the treatment of thoracic malignancies.
Passiglia F, Reale ML, Cetoretta V, Parlagreco E, Jacobs F, Listì A, Righi L, Bironzo P, Novello S, Scagliotti GV. Passiglia F, et al. Among authors: parlagreco e. Cancer Treat Rev. 2021 Sep;99:102256. doi: 10.1016/j.ctrv.2021.102256. Epub 2021 Jul 7. Cancer Treat Rev. 2021. PMID: 34261032 Review.
Prognostic significance of laterality in lung neuroendocrine tumors.
La Salvia A, Persano I, Siciliani A, Verrico M, Bassi M, Modica R, Audisio A, Zanata I, Trabalza Marinucci B, Trevisi E, Puliani G, Rinzivillo M, Parlagreco E, Baldelli R, Feola T, Sesti F, Razzore P, Mazzilli R, Mancini M, Panzuto F, Volante M, Giannetta E, Romero C, Appetecchia M, Isidori A, Venuta F, Ambrosio MR, Zatelli MC, Ibrahim M, Colao A, Brizzi MP, García-Carbonero R, Faggiano A. La Salvia A, et al. Among authors: parlagreco e. Endocrine. 2022 Jun;76(3):733-746. doi: 10.1007/s12020-022-03015-w. Epub 2022 Mar 18. Endocrine. 2022. PMID: 35301675 Free PMC article.
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis.
Turco F, Tucci M, Angusti T, Parente A, Di Stefano RF, Urban S, Pisano C, Samuelly A, Audisio A, Audisio M, Parlagreco E, Ungaro A, Scagliotti GV, Di Maio M, Buttigliero C. Turco F, et al. Among authors: parlagreco e. Tumori. 2023 Apr;109(2):233-243. doi: 10.1177/03008916221077144. Epub 2022 Mar 31. Tumori. 2023. PMID: 35361017
15 results